A double-blind trial of budesonide and betamethasone-17, 21-dipropionate in psoriasis

References

• Agrup G., Björnberg A., Elmros T., Groth O., Hannuksela M., Lassus A., Salde L., Skogh M., Thomsen K. Clinical trial of a potent non-halogenated topical steroid—budesonide. Acta Derm. Venereol. (Stockh 1981; 61: 1801. Agrup G., Björnberg A., Elmros T., Groth O., Hannuksela M., Lassus A., Salde L., Skogh M., Thomsen K. Clinical trial of a potent non-halogenated topical steroid—budesonide. Acta Derm. Venereol. (Stockh 1981; 61: 180
   PubMed Web of Science ®Google Scholar
• Agrup G., Lassus A., Lidén S., Osmundsen P. E., Rajka G., Søndergaard J. Classification of modern corticosteroid preparations (In Swedish). Läkartidningen 1978; 19: 1924, (English summary).2. Agrup G., Lassus A., Lidén S., Osmundsen P. E., Rajka G., Søndergaard J. Classification of modern corticosteroid preparations (In Swedish). Läkartidningen 1978; 19: 1924, (English summary).
   Google Scholar
• Allen A. M. Clinical trial design in dermatology: Experimental design. Part 1. Int.J. Dermatol 1978; 17: 423. Allen A. M. Clinical trial design in dermatology: Experimental design. Part 1. Int.J. Dermatol 1978; 17: 42
   PubMed Web of Science ®Google Scholar
• Degreef H., Salde L. A double-blind comparative trial of budesonide 0.025% ointment and betamethasone-17.21-dipropionate 0.05% ointment in psoriasis. Curr. Ther: Res 1981; 29: 8804. Degreef H., Salde L. A double-blind comparative trial of budesonide 0.025% ointment and betamethasone-17.21-dipropionate 0.05% ointment in psoriasis. Curr. Ther: Res 1981; 29: 880
   Web of Science ®Google Scholar
• Eriksen K. Comparison of clobetasol propionate and betamethasone-17, 21-dipropionate with reference to adrenal suppression. Acta Derm. Venereol. /Stockh 1978; 59: 3725. Eriksen K. Comparison of clobetasol propionate and betamethasone-17, 21-dipropionate with reference to adrenal suppression. Acta Derm. Venereol. /Stockh 1978; 59: 372
   Web of Science ®Google Scholar
• Gomez E. C., Kaminester L., Frost P. Topical halcinonide and betamethasone valerate effects on plasma cortisol. Arch. Dermatol 1977; 113: 11966. Gomez E. C., Kaminester L., Frost P. Topical halcinonide and betamethasone valerate effects on plasma cortisol. Arch. Dermatol 1977; 113: 1196
   PubMed Web of Science ®Google Scholar
• Gruvstad E., Bengtsson B. A comparison of a new steroid, budesonide, with other topical corticosteroids in the vasoconstriction assay. Drugs Exp. Clin. Res 1980; 6: 3857. Gruvstad E., Bengtsson B. A comparison of a new steroid, budesonide, with other topical corticosteroids in the vasoconstriction assay. Drugs Exp. Clin. Res 1980; 6: 385
   Google Scholar
• Kligman A. M., Frosch P. J. Steroid addiction. Int. J. Dermatol 1979; 18: 218. Kligman A. M., Frosch P. J. Steroid addiction. Int. J. Dermatol 1979; 18: 21
   Google Scholar
• Lassus A., Salde L. A double-blind comparison of two topical steroids in psoriasis and eczemas: budesonide 0.025% ointment and betamethasone-17-valerate 0.1% ointment. Pharmatherapeutica 1981; 2: 6679. Lassus A., Salde L. A double-blind comparison of two topical steroids in psoriasis and eczemas: budesonide 0.025% ointment and betamethasone-17-valerate 0.1% ointment. Pharmatherapeutica 1981; 2: 667
   Google Scholar
• Miller J. A., Munro D. D. Topical corticosteroids: clinical pharmacology and therapeutic use. Drugs 1980; 19: 11910. Miller J. A., Munro D. D. Topical corticosteroids: clinical pharmacology and therapeutic use. Drugs 1980; 19: 119
   PubMed Web of Science ®Google Scholar
• Ryrfeldt Å R., Andersson P., Edsbäcker S. Liver and skin biotransformation of glucocorticosteroids in hairless mouse. rat and man. “Abstracts of the 22nd Nordic Conference on Dermatology”, K. Mustakallio, L. Förström. Helsinki., 198011. Ryrfeldt Å R., Andersson P., Edsbäcker S. Liver and skin biotransformation of glucocorticosteroids in hairless mouse. rat and man. “Abstracts of the 22nd Nordic Conference on Dermatology”, K. Mustakallio, L. Förström. Helsinki., 1980
   Google Scholar
• Schmidt H., Hjorth N., Salde L. A double-blind trial of budesonide ointment and betamethasone-17-valerate ointment in psoriasis. J. Int. Med. Res 1981; 9: 23612. Schmidt H., Hjorth N., Salde L. A double-blind trial of budesonide ointment and betamethasone-17-valerate ointment in psoriasis. J. Int. Med. Res 1981; 9: 236
   PubMed Web of Science ®Google Scholar
• Schöpf E. Side-effects of topical steroid therapy. Ann. Clin. Rex 1975; 7: 35313. Schöpf E. Side-effects of topical steroid therapy. Ann. Clin. Rex 1975; 7: 353
   PubMedGoogle Scholar
• Thalén A., Brattsand R. Synthesis and anti-inflammatory properties of budesonide. A new non-halogenated glucocorticoid. Arzneim. Forsch 1979; 29: 168714. Thalén A., Brattsand R. Synthesis and anti-inflammatory properties of budesonide. A new non-halogenated glucocorticoid. Arzneim. Forsch 1979; 29: 1687
   PubMed Web of Science ®Google Scholar
• Wendt H., Mugglestone C. J., Wiseman R. A. A study of the comparative efficacy of diflucortolone valerate 0.3% ointment and clobetasol propionate 0.05% ointment. Br. J. Dermatol 1978; 99: 41115. Wendt H., Mugglestone C. J., Wiseman R. A. A study of the comparative efficacy of diflucortolone valerate 0.3% ointment and clobetasol propionate 0.05% ointment. Br. J. Dermatol 1978; 99: 411
   PubMed Web of Science ®Google Scholar
• Wilson L. The clinical assessment of topical corticosteroid activity. Br. J. Dermatol 1976; : 17–4216. Wilson L. The clinical assessment of topical corticosteroid activity. Br. J. Dermatol 1976;. : 17–42
   PubMedGoogle Scholar